HAMPTON, Va.--(BUSINESS WIRE)--HST Global, Inc. (OTCBB: HSTC), a development stage biotechnology company, today announced that it has asked EBITDA Capital to assist in the selection of its FDA legal team and EBITDA Capital has assigned the process to Roman Buhler.
